Quinolones.
Shah
P M
PM
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin; D015365:Enoxacin; D006801:Humans; D008826:Microbial Sensitivity Tests; D009287:Naphthyridines; D009643:Norfloxacin / Q000031:analogs & derivatives; D015242:Ofloxacin; D010078:Oxazines; D015366:Pefloxacin; D011804:Quinolines / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D009287:Naphthyridines; D010078:Oxazines; D011804:Quinolines; D015366:Pefloxacin; D015365:Enoxacin; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin